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Background: Obesity is associated with increased risk and poor prognosis of triple negative breast 
cancer (TNBC), a highly aggressive subtype of breast cancer with high rates of metastasis and 
recurrence. Previous research from our lab showed calorie restriction (CR) has an antitumorigenic 
effect against TNBC, although mechanisms remain unclear. We hypothesize that CR may facilitate 
this anticancer effect, at least in part, via upregulation of microRNA (miR)-15b and subsequent 
disruption of IGF-1 system activation.  
 
Methods: cBioPortal, TargetScan, miRTarBase, and various TCGA data sets were utilized to 
conduct in silico analysis of potential genes and target pathways associated with miR-15b 
expression, especially along the PI3K/Akt/mTOR pathway.  To mimic caloric restriction in vitro, 
M6 and M6C cells derived from the C3-Tag series progression cell were treated with several 
nutrient restricted medias including reduced serum, BMS754807 (inhibitor of IGF1-R), IGF-1, 
and different combinations of these three conditions. To characterize the impact of caloric 
restriction on these cells and their potential mechanistic action, qPCR was performed on miRNA 
and mRNA collected to determine fluctuations in levels of miR-15b and IGF1-R.  
 
Results: The qPCR analysis performed in vitro did not yield any statistically significant results 
demonstrating the impact of caloric restriction on miR-15b or IGF1-R. However, in silico analyses 
revealed that miR-15b overexpression in human breast tumors was associated with increased 
expression of genes associated with regulation of breast cancer cell proliferation, while decreased 
miR-15b was associated with enhanced growth factor signaling and epithelial-to-mesenchymal 
transition. 
 
Conclusion: In silico studies suggest the anticancer effects of CR in a murine model of TNBC 
may be mediated, at least in part, through increased miR-15b expression and subsequent targeting 
of the IGF1 axis regulating downstream genes involved in breast cancer cell proliferation and 
progression. However, several sources of error could have impacted the in vitro component of this 
study, indicating that further analyses are necessary to confirm the interaction amongst caloric 
restriction, miR-15b, and IGF-1 system activation of the PI3K/Akt/mTOR pathway.   




Triple-negative breast cancer lacks adequate molecular targets.  The most diagnosed cancer 
in women and the second-most deadly only behind lung cancer, breast cancer is a highly 
devastating disease that impacts every 1 in 8 women born in the United States (1,2). Comprising 
approximately 20% of diagnosed breast cancers, triple negative breast cancer (TNBC) is a highly 
aggressive breast cancer subtype with a greater potential to metastasize and recur than all other 
subtypes. While the five-year survival rate for other subtypes averages at 93%, the five-year 
survival rate for TNBC is only 77% (3). Additionally, black women are twice as likely to be 
diagnosed with TNBC than white women (4). The prognosis for TNBC is particularly devastating 
because it lacks the three molecular targets that can be inhibited by hormone-targeted therapies 
(estrogen, progesterone, and HER2/neu receptors), leaving patients no other option than 
undergoing the traditional yet physically harmful process of cytotoxic chemotherapy (5). Because 
of the numerous negative side-effects associated with chemotherapy treatment such as anemia, 
severe fatigue, and alopecia, and the known disparities in disease burden across racial and ethnic 
groups, researchers have long sought more effective, alternative treatments with fewer adverse 
effects. 
 
Dietary energy balance impacts cancer risk and progression. Obesity is an established risk 
factor for breast cancer development (5-7), and weight gain throughout life, as well as after 
diagnosis, has been shown to decrease survival in both pre- and post-menopausal breast cancer 
patients (8-10).  Furthermore, obesity has been shown to modulate the severity of symptoms 
present in patients with breast cancer (6) and post-menopausal patients diagnosed with TNBC 
specifically are more likely to be overweight/obese than at a healthy weight (7). For each BMI unit 
increase, the breast cancer mortality risk increases by 8-29%, dependent on the initial BMI taken 
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for a patient (8). Additionally, obesity has been shown to drive indicators of poorer prognoses such 
as tumor size, tumor grade, and metastasis (9). It is also known to play a role in increasing several 
pro-inflammatory pathways that can contribute to heterogeneity within the tumor 
microenvironment by maintaining cancer stem cell populations, leading to tumor development and 
invasion (10).    
One therapeutic avenue that has shown promise in treatment of TNBC while reducing the 
consequences of cytotoxic chemotherapy is dietary caloric restriction (CR).  In CR, a patient 
receives complete nutrition while reducing calorie intake (11). Previous studies in the Hursting lab 
have indicated that CR diets in mouse models of TNBC not only significantly improve the length 
of tumor-free survival and overall survival of mice, but also decrease total tumor count and average 
secondary tumor weight (12). This data is shown in figure 1. 
Figure 1: Survival curve depicting improved tumor-free survival (A) and overall survival (B) from in 
vivo studies done on C3(1)-Tag spontaneous tumor mouse models fed a 30% CR diet compared to a 
control ad libitum diet. Mice on CR diets also had lower overall tumor count (C) and decreased 
secondary tumor weight (D). *, P<0.05; **, P<0.001; ***, P<0.0001. 
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IGF signaling is vital to cancer development. Synthesized in the liver, IGF-1 is a peptide 
hormone integral to mediating somatic development initially stimulated by growth hormone, and 
is especially important in regulating the cell cycle process. CR in both humans and animal models 
decreases circulating levels of IGF-1 (Figure 2). IGF-1 functions by binding to insulin-like growth 
factor 1 receptor (IGF-1R) to activate the phosphatidylinositol-3 kinase (PI3K)/Akt pathway, 
which controls multiple downstream mediators such as the mammalian target of rapamycin 
(mTOR).  This tyrosine kinase receptor cascade pathway is vital to maintaining appropriate 
nutrient levels to control development, protein synthesis, and overall survival in the cell (14). IGF 
signaling is important in tumor development 
because it increases cell proliferation while 
inhibiting apoptosis in cancer cells. 
Additionally, IGF signaling is frequently high 
in patients whose lifestyles are characterized 
by minimal exercise and dietary choices high 
in fat and animal proteins (15).  
 In breast cancer, several studies have shown that IGF-1 levels play a crucial role in 
mammary tumorigenesis. Studies performed in murine models have demonstrated that mammary 
tumor development was impeded in mice with reduced IGF-1 levels (16). Moreover, the ability to 
undergo oncogenic transformation depends on the IGF-1/IGF-1R interaction and activation of 
downstream signaling (17). In addition, another study specifically examined IGF-1’s role in seven 
different triple negative breast cancer cell lines. The results of this study displayed that IGF-1 
increased the proliferation and survival rate of all cell lines compared to their controls (18). 
Furthermore, it is widely recognized that elevated levels of both systemic and tumor IGF-1 are 
Figure 2: Plot displaying increased concentration 
of IGF-1 present in the circulation of mice fed a 
control diet (black) vs a CR diet (red).  
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strong determinants of a patient’s prognosis following diagnosis with triple negative breast cancer 
(19). 
 
IGF-1R is a potential target of microRNA-15b. While there are several molecular targets under 
CR’s comprehensive reach, previous studies performed in our laboratory have led us to suspect 
that miRNA-15b may be a key mediator of CR’s antitumorigenic effects in TNBC. miRNAs are 
small strands (~22 nucleotides long) of highly conserved non-coding RNA that are important in 
gene regulation. They are generated from a set of precursors that undergo several cleavage events 
before arriving at the final miRNA form (20). miRNAs target mRNA transcripts by binding to the 
3’ UTR of the mRNA with their seed sequences, which are usually nucleotides 2-7 of the miRNA 
(21). In most animal models, the seed sequences are partially complementary (meaning the entire 
seed sequence is not a perfect match), which leads to partial mRNA degradation or translational 
repression, leading to reduced protein expression rather than complete elimination of expression 
(22). However, in the case of full complementarity there can be total destruction of the mRNA 
sequence.  Regardless of the extent of a miRNA’s complementarity, any deterioration that occurs 
is completed as complementary sequences lead to formation of the RISC complex (RNA-induced 
silencing complex), which consists of a group of ribonucleoproteins that position a gene target for 
recognition and cleavage by other Argonaute proteins (23).  Previous work completed in the 
Hursting Lab has shown that in the C3(1)-Tag mouse models fed either a control diet of a 30% CR 
diet, gene expression of miR-15b was significantly increased while expression of IGF1-R was 
significantly reduced in relative protein quantity and gene expression. This relationship is depicted 
in figure 3. miR-15b’s inhibitory effect towards this transmembrane receptor may be the 
mechanism by which CR’s anti-cancer and tumor suppressing processes are occurring. With 
decreased receptor expression, IGF-1 is unable to exert its effects via the PI3K/Akt/mTOR 
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pathway to enhance proliferation, growth, survival, and development of TNBC cells. TNBC’s 
deadly progression has a clear correlation with obesity, and it is paramount that the mechanism by 





























Figure 3: (A) Graph illustrating the 
increased relative expression of miR-
15b in tumors from C3(1)-Tag mice fed a 
CR diet compared to a control diet. CR 
Mice also showed decreased levels of 
IGF1-R. (B) shows the relative gene 
expression of IGF1-R via qPCR, while 
(C) shows western blots of IGF1-R 
protein expression with relative 
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Goals and Hypotheses 
The goal of this project is to determine the role that miR-15b plays in the relationship 
between caloric restriction and triple-negative breast cancer in order to better understand the 
mechanisms underlying breast cancer development and metastasis.  A more comprehensive 
understanding of these processes could potentially lead to newer and safer treatment plans for 
patients with TNBC to avoid the detrimental consequences of cytotoxic therapy.  
Aim 1. Identify predicted targets of miR-15b and global effects of miR-15b expression in silico 
miRNAs are responsible for a diverse, global range of regulatory effects within the cell, as each 
miRNA is suspected to target hundreds of mRNAs, even though miRNAs themselves compose 
only 0.01 % of all total RNA (24,25). Fortunately, there are bioinformatic databases with resources 
that can provide predicted gene targets of miRNAs, published literature on experimentally 
validated miRNA-target interactions, and molecular pathways they may be involved with. 
Analysis of this data will reveal how miR-15b and its predicted targets are involved in the 
PI3K/Akt/mTOR pathway signaling and oncogenic signaling regulation overall. 
Aim 2. Determine the relationship between IGF-1 system activation and miR-15b 
Two C3(1)-Tag progression series cell lines, the M6 and M6C cells, were cultured in various 
nutrient restricted cell medias and analyzed for alterations in both protein and gene expression. It 
is hypothesized that miR-15b expression will be upregulated in cells with greater nutrient 
restriction and that these changes will be more pronounced in the less aggressive cell lines. 
Furthermore, it is postulated that expression of genes and proteins involved in the activation of the 
PI3K/Akt/mTOR pathway will be reduced in cells with greater nutrient restriction and that 
regulation will correspond to the cell line’s aggressiveness.  
 




Gene Expression Analysis   
For each sample, total RNA was first isolated from cells with the use of TRIzol reagent 
from ThermoFisher Scientific, which was utilized according to the manufacturer’s instructions. 
The Omega Bio-Tek E.Z.N.A. Micro RNA Kit was used to extract pure fractions of both mRNA 
and miRNA simultaneously from the same samples with the use of spin columns according to the 
manufacturer’s protocol. Both concentration and quality of miRNA and RNA collected from each 
sample were analyzed with the use of a Nanodrop 2000 spectrophotometer. For miRNA, cDNA 
was synthesized using the TaqMan
 
Advanced miRNA cDNA Synthesis Kit according to 
manufacturer’s instructions. For mRNA, cDNA was prepared using the Applied Biosystems High-
Capacity cDNA Reverse Transcription Kit. qPCR reaction mixes were prepared using the TaqMan
 
Universal Master Mix II paired with TaqMan
 
Advanced miRNA assay (for miRNA) or TaqMan 
gene expression assay (for mRNA) in conjunction with RNase-free water and the synthesized 
cDNA. Assays were seeded in triplicate and run on an Applied Biosystems ViiA 7 Real-Time PCR 
system according to the instructions provided by the manufacturer. The Ct method was utilized 
to complete all relative expression calculations and generate an RQ value for each sample. The 
reference gene used for the miRNA analyses performed was miR-16-5p, while beta-actin as used 
for mRNA assays, as suggested by the manufacturer.  
TargetScan/miRTarBase Analysis 
The target prediction process first began with the generation of a consensus list of predicted 
targets using TargetScan Release 7.2 (26) .This program predicts gene target lists for specific 
miRNAs by attempting to find the best match between the conserved sequences of target genes 
and the seed region of a given miRNA (nucleotides 2-8). TargetScan then scores targets using the 
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context++ score measure of association, which ranks predictions based on their predicted targeting 
efficacy. Additionally, it scores targets with PCT (probability of conserved targeting), a measure 
that further ranks targets based on their probability of targeting the seed sequence of a miRNA, a 
highly conserved region across most species. Based on previous literature and studies done using 
target prediction databases for miRNAs (27,28), a cutoff score of -0.3 for context++ score was set 
and only values below this score were accepted as potential targets. For PCT, a cutoff score of 0.75 
was used and only values above this were accepted as suitable targets. Using these parameters, the 
lists of predicted genes for the two mature forms of human and mouse miR-15b (hsa-miR-15b-5p, 
mmu-miR-15b-5p, hsa-miR-15b-3p, and mmu-miR-15b-3p) were filtered and compared. After 
this data was filtered, the narrowed list of potential gene targets was subject to further comparison 
in miRTarBase, a database that has stored more than 300,000 miRNA-gene target interactions that 
have been verified experimentally and published in the literature (29). In addition to miRTarBase 
analysis, the common gene targets of mmu-miR-15b-5p and hsa-miR-15b-5p obtained from 
TargetScan were also entered into the Database for Annotation, Visualization, and Integrated 
Discovery (DAVID) (29). DAVID performs a functional interpretation of entered gene lists to 
provide insight into which hallmark or oncogenic biochemical pathways the individual genes are 
a part of to determine the overall biological impact of changes in the gene list. It clusters separate 
genes into groups and shows the variety of pathways genes may be impacting along with the 
statistical significance of the probability that the pathway is being affected.    
miR-15b Expression Correlation Analyses  
Further target prediction analysis was completed with the use of MD Anderson Cancer 
Center’s TCGA standardized data (32). TCGA is a public collection of molecular data sets 
generated using the tumors of over 10,000 cancer patients and accessible to cancer researchers 
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anywhere in the world for statistical analysis (31). This pool of data sets contains information 
about many tumor samples from various institutions at different times to discern genomic, 
proteomic, and transcriptomic trends that may be facilitating cancer-causing processes. In this 
instance, TCGA analysis via MD Anderson’s collection of patient breast cancer tumor samples  
from their institutions was utilized in order to compare correlations in Reverse Phase Protein Array 
data (RPPA) and miR-15b expression along with correlations between miR-15b and Illumina 
RNA-sequencing (RNA-seq) data. By aligning the matrix data given for both RPPA and RNA-seq 
with miR-15b relative to breast cancer tumor samples, a protein list and gene list could both be 
generated and tested for significance of association with miR-15b. Lists were generated for both 
positive and negative correlating genes and proteins. Once significant gene and protein lists from 
the human tumor sample data were determined with the use of Pearson coefficient, T-value, p-
value, and q-value statistics, the lists were each entered into DAVID to obtain functional 
interpretations of which pathways miR-15b may be playing a role in based on clustering and 
ranking of significant gene and protein groups. If results were insignificant, manual probing of the 
dataset was employed to examine lists and determine associations based on existing literature.  
miR-15b Amplification Analyses 
More in silico investigation of miR-15b’s role in breast cancer was executed by probing 
human datasets on the human cancer data repository cBioPortal. It allows for download and 
visualization of these large-scale datasets for further analysis (32).  Two of the largest breast cancer 
datasets, METABRIC (2509 samples) and TCGA BRCA (1084 samples) were probed for 
alterations in miR-15b. Then, gene expression was compared between tumor samples of patients 
with miR-15b alterations and those without. Genes that were significantly altered were then 
entered into Gene Set Enrichment Analysis (GSEA) online for pathway analysis. GSEA is a 
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computational method to show statistically significant relationships or differences between two 
biological states of a set gene list (33). In this analysis, overexpressed genes and under expressed 
genes were separated into different pools to maintain proper directionality of data. Specifically, 
both the Hallmarks gene sets and the C3 gene sets were observed in order to examine overall 
changes and C3 miRNA-specific changes, respectively. A flowchart summary of analyses using 
TCGA and METABRIC data can be seen in Figure 4.  
Cell Culture 
M6 and M6C cell lines were utilized for all in vitro experiments. These cell lines were 
generated following isolation of tumors from the C3(1)-Tag spontaneous model. The C3(1)-Tag 
transgenic line models basal-like breast cancer, and both the M6 and M6C cluster basal-like as 
well. The M6 and M6C are part of a larger progression series. The M6 was isolated from a primary 
C3(1)-Tag lesion, while the M6C was isolated from a lung metastatic nodule following 
subcutaneous injection of M6 cells into a nude mouse. M6 and M6C cell lines were cultured in 
high-glucose (25 mM) DMEM media supplemented with 10% FBS, 25 mM HEPES, 100 U/mL 
Pen/Strep, 1 mM Sodium Pyruvate, and 2 mM glutamine (complete media/CM). In order to mirror 
caloric restriction in vitro, ~300,000 cells of each C3-tag line were seeded into 6 cm plates 
containing and treated with one of the following treated media conditions for 18 hours: CM, CM 
Figure 4: Flowchart depicting METABRIC and TCGA BRCA analyses.  
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+ 100 nM BMS754807 (inhibitor of IGF1-R), Serum starvation (SS, CM with no FBS 
supplementation), SS + 10 ng/mL IGF-1, SS + BMS754807, and SS + 10 ng/mL IGF-1 + 


















In Vitro Gene Expression Results 
 
In order to characterize the role of caloric restriction on miRNA and mRNA involved in 
the PI3K/Akt/mTOR pathway in vitro, qPCR was utilized to profile relative expression of miR-
15b and IGF1-R. It was hypothesized that miR-15b would have an inverse relationship with the 
aggressiveness of a cell line and IGF-1R would positively correlate with a cell line’s 
aggressiveness based on previous pilot data. However, both qPCR of miR-15b and IGF1-R in 
various conditions of nutrient restriction revealed no significant differences in expression among 




Figure 5A: Gene expression of miR-15b obtained via qPCR for both M6 (invasive carcinoma) 
and M6C (metastatic) cell lines.  
Figure 5B: Gene expression of IGF1-R obtained via qPCR for both M6 (invasive carcinoma) 

















































































































In Silico Target Prediction Results  
Using TargetScan and the determined cutoff scores for context++ score and PCT, a list of 
three genes was determined that overlap as potential  targets of miR-15b in both mouse and human 
models. To gain a more comprehensive view of further genes that miR-15b potentially impacts, 
the gene list was filtered solely based on context++ score and this list expanded to six genes. This 
list included genes VAPB, TGIF2, UBE2Q1, ATXN7LS, TRANK1, and ATXN7LSB. Using 
miRTarBase, this expanded gene list was analyzed for any miR-15b gene-target interactions that 
have been verified experimentally. This analysis showed that both ATXN7LSB and TRANK1 had 
been confirmed in vitro via Next-Generation Sequencing (NGS*) in human samples. Additionally, 
ATXN7LSB has two publications discussing this gene-target interaction, while TRANK1 has 
three publications discussing this gene-target interaction. There were no mouse model gene-target 
interactions confirmed experimentally based on the list obtained from TargetScan analysis.  Figure 
6A displays the gene target alignment performed based on both context++ score and PCT, while 
figure 6B shows the gene target alignment performed on the expanded gene list based only on 
context++score. Table 1 shows the results of the miRTarBase analysis that was performed.  
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Figure 6A: Alignment for potential gene targets of miR-15b in both mouse and human models 
based on both context++ score and PCT. The leftmost circle contains all the genes that met these 
criteria for humans, the rightmost circle contains all the genes that met these criteria for mice, and 
the middle overlap represents the number of genes in common between the two species. 
  
Figure 6B: Alignment for potential gene targets of miR-15b in both mouse and human models 
based on context++ score. The leftmost circle contains all the genes that met these criteria for 
humans, the rightmost circle contains all the genes that met these criteria for mice, and the middle 





Table 1: miRTarBase was used to determine gene-target interactions confirmed in an array of 
different experiments. The NGS* results obtained were only confirmed in human samples. There 
were no confirmed interactions in the mouse model.   
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The results of cBioPortal analysis revealed several hallmark pathways miR-15b may be 
affecting, general and specific gene expression of samples with miR-15b amplification, and the 
overall relationship between IGF1-R and survival. Table 2 lists the top 15 significantly enriched 
pathways in genes significantly underexpressed in samples with miR-15b amplification compared 
to non-amplified samples. Pathways known to be involved in cancer growth and progression, such 
as estrogen signaling, fatty acid metabolism, and epithelial-to-mesenchymal transition, were all 
significantly decreased in samples with amplified miR-15b expression. In contrast, Table 3 shows 
the top 15 hallmark pathways in genes overexpressed in miR-15b amplified samples. Significantly 
associated pathways in these samples were also related to cancer proliferation, particularly that of 
cell cycle processes, and may indicate a more proliferative and less invasive phenotype in tumors 
with high levels of miR-15b. We also wanted to test how significantly affected genes in these 
samples fit with known targets of miRNA. Table 4 shows that, in samples with miR-15b 
amplification, we observe a significant decrease in gene expression of predicted target genes for 
miR-15b and its family of miRs. Additionally, we specifically wanted to see how miR-15b 
amplification affected IGF1R expression within breast tumors. Table 5 shows relative 
underexpression of IGF1-R in samples with miR-15b amplification compared to those without it. 
What is also striking about these data in tables 2-5 is the congruence between both the METABRIC 
and TCGA datasets, indicating that these are true differences observed in breast cancer and not an 
artifact of a single dataset. Lastly, cBioPortal analysis was able to provide Figure 7, which plotted 
the overall survival of breast cancer patients against expression of IGF1-R. The red line on the 
figure represents calculation of survival based on the gene query alteration for increased IGF1-R 
expression, and it illustrates a reduced probability of survival with increased IGF1-R expression.    




Table 2: cBioPortal analysis of significantly underexpressed hallmark pathways in tumor 
samples with miR-15b amplification. 
 




Table 3: cBioPortal analysis of significantly overexpressed hallmark pathways in tumor samples 
with miR-15b amplification. 
 
 
Table 4: cBioPortal analysis of samples with miR-15b amplification, showing  a significant 












Table 5: cBioPortal analysis of relative underexpression of IGF1-R in samples with miR-15b 





Figure 7: cBioPortal Analysis of the relationship between overall survival of breast cancer patients 
and relative IGF1-R expression. The red line indicates the decreased survival resulting from 
increased IGF1-R expression. 
 
 The results of DAVID analysis proved to be non-significant when performed on the list of 
genes predicted by TargetScan based on both PCT and context++ score and on the list of genes 
predicted based only on context++ score. There was some correlation to important pathways that 
could be involved in cancer progression such as signaling peptides and transcription regulation, 
but none of these associations reached a p-value less than 0.1. DAVID analysis of the proteins 
significantly associated with miR-15b expression data from TCGA was insignificant for those 
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positively correlated and those negatively correlated, but manual clustering revealed positive 
association with cell cycle and proliferation and a negative association with growth factor signaling 
and breast cancer metastasis. These results are shown in Table 6. However, DAVID analysis of 
the significant gene lists positively and negatively correlating with miR-15b expression in samples 
had significant correlation with cancer development pathways. The results generally depict that 
miR-15b correlates with a down regulation of genes in growth-factor signaling processes and an 
upregulation of genes regulating cell proliferation. The pathways positively correlating with miR-
15b expression are displayed in Table 7, and the pathways negatively correlating with miR-15b 
expression are shown in Table 8.  
 
 
Table 6: Manual clustering of the proteins significantly upregulated and downregulated with miR-
15b expression in patient tumor samples. 
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Table 7: DAVID analysis of the pathways positively correlating with miR-15b expression in 
patient tumor samples. 
 




Table 8: DAVID analysis of the pathways negatively correlating with miR-15b expression in 












TargetScan/miRTarBase   
 
Although the genes that miR-15b is predicted to target in both mouse and human models 
did not provide significant results when using TargetScan and miRTarBase, it has been recognized 
in previous literature that score prediction methods such as those of TargetScan should not be used 
so stringently when searching for potential gene-target interactions (34). When using cutoffs as a 
hard filter, there is potential for loss of real targets of miR-15b. This is because detection curves 
for matches to the conserved site initially increase at the same rate, but when conversed sites in 
the 5% most downregulated set are depleted, the detection rate for matches to the conserved site 
starts to level out. Therefore, a large number of downregulated targets (such as IGF1-R) can easily 
be missed when using these methods. These predictive scoring methods should be used in 
conjunction with other detailed measures. 
Likewise, miRTarBase also should not be used as the only gauge of potential gene-target 
interactions. Although this database contains information from hundreds of thousands of miRNA 
functional studies, it is important to note that it only provides information on those that have been 
validated experimentally. Although it saves the researcher the burden of individually reviewing all 
relevant literature for a miRNA of interest, it is very possible that some of the predicted targets of 
miR-15b entered into miRTarBase simply have not been studied in enough detail yet. Therefore, 
it is unsurprising that miRTarBase was devoid of more information because it is likely that there 
are several more targets of miR-15b that simply lack experimental confirmation.  
DAVID 
The DAVID analyses performed only provided significant results for the genes obtained 
from the RNA-seq data that was correlated with miR-15b from the MD Anderson TCGA 
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Standardized Data Browser. It is likely that DAVID requires a large enough number of genes or 
proteins to be able to find significantly associated pathways because the RNA-seq data was 
comprised of 844 samples in comparison to the aligned RPPA proteins (92 samples) and the 
TargetScan gene list based on context++ score (41 samples).  
However, manual clustering was still possible for the proteins significantly correlating both 
positively and negatively with miR-15b expression and these results were depicted in Table 6. This 
analysis revealed an upregulation of proteins involved with cell cycle and proliferation along with 
a downregulation of proteins involved in growth factor signaling and breast cancer metastasis. The 
results of the manual clustering were important not only because they provide confirmation of the 
data obtained through DAVID and GSEA analysis, but also because it showed a significant 
decrease in the number of phosphorylated growth factor receptors involved in major cell signaling 
pathways such as EGFR, HGFR, and most notably IGF1-R. This helps us verify how miR-15b 
may not only inhibit the receptor of these processes, but also system activation as a whole because 
it could be repressing downstream phosphorylation of key protein mediators of oncogenic 
mechanisms.   
Table 7 illustrates the various pathways impacted by genes positively correlated with miR-
15b expression. The clusters for positive correlation indicate that miR-15b may significantly 
increase genes involved in cell cycle regulation and various cell division processes. This is an 
important association because if miR-15b is increasing these regulatory genes, its protective effects 
could be the result of its influence on cell proliferation and development. With more genes for 
proper cell cycle completion, TNBC cells could have more difficulty evading its regulatory 
checkpoints, or could simply be in a more proliferative state compared to a more aggressive 
invasive state. Likewise, the impact of greater expression of genes involved in DNA replication 
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and mitosis could hinder the uncontrolled proliferation of TNBC cells. Table 8 shows the different 
pathways impacted by genes negatively correlated with miR-15b expression. These pathways 
seemed to be mostly related to epidermal growth-factor and other general signaling mechanisms. 
This table is critical to our hypothesis because if miR-15b is significantly altering IGF-1 system 
activation as predicted, then it is important that it is associated with a downregulation of genes 
involved with peptide or glycosylation signaling. These are two known methods by which 
pathways are able to transmit signals throughout the cell. Additionally, a negative association with 
epidermal growth factor (EGF) and its receptors was correlated with miR-15b overexpression. 
This is important to note because EGF has an analogous function to IGF-1 in terms of initiating 
tyrosine receptor phosphorylation cascades. In fact, EGF and IGF have been discovered to be 
closely associated in downstream signaling pathways related to therapy resistance in breast cancer, 
and there is likely significant crosstalk between EGF and IGF pathways (35).  
 
cBioPortal 
In Table 2, it was determined through cBioPortal analysis that the negatively correlating 
gene list was significantly associated with hallmark pathways in cancer development such as fatty 
acid metabolism, epithelial-to-mesenchymal transition (EMT), p53 pathway signaling, and KRAS 
pathway signaling. The downregulation of such pathways when exposed to miR-15b amplification 
are indicative of miR-15b’s potentially antitumorigenic effects, and it highlights ways in which 
miR-15b may be accomplishing this outside the scope of just IGF-1 signaling pathways. Table 3 
displays the list of upregulated hallmark pathways determined from the list of genes positively 
correlating with miR-15b. From this list, it is observed that pathways such as cell cycle regulation 
and cell division were upregulated based on the list of genes positively correlating with miR-15b. 
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This matches up with the pathways predicted to be upregulated after the alignment of RNA-seq 
data from MD Anderson’s patient sample repository with miR-15b and analysis with DAVID. As 
mentioned before, this is important because miR-15b’s potential influence on increasing genes 
implicated in cell cycle regulation could be important to discovering how it may be skipping 
regulatory checkpoints and proliferating without control.  
Table 4 is a short but compelling figure because it is able to show that in samples with 
miR-15b amplification, we see significant downregulation of genes that are hypothesized to be 
targets of miR-15b and its related miRs. cBioPortal analysis was also able to provide table 5, which 
specifically looked at the impact of miR-15b’s amplification on IGF1-R relative expression. In 
both datasets there was a significant decrease in IGF1-R expression, once again reinforcing the 
support for potential miR-15b mediated downregulation of IGF1-R. Furthermore, both the 
METABRIC dataset and the TCGA BRCA data sets depicted a very similar alterations in genes 
both over- and under-expressed in tumors with miR-15b amplification. This displays how there is 
concordance between both data sets and strong evidence for miR-15b’s in silico predictions, as 
these findings are reproducible across two of the largest breast cancer datasets available. 
Lastly, figure 7 provided a wholistic interpretation of IGF1-R’s role in overall survival of 
TNBC patients. The graphic produced illustrated how greater relative expression of IGF1-R is may 
decrease overall survival in patients with breast cancer. This figure is important to consider 
because if miR-15b’s antitumorigenic effects are taking place through inhibition of IGF1-R 
expression, it could also be playing an important role in the disease course of TNBC. By better 
understanding and confirming miR-15b’s interactions with IGF1-R through experimentation, the 
full scope of its inhibitory capabilities could be realized and harnessed as a potential intervention 
for TNBC patients.  




Upon completion of qPCR for both the miRNA and mRNA obtained from all the samples 
exposed to differing nutrient conditions, it was determined that there were no significant 
differences between the control group and any of the nutrient restricted groups that were studied. 
Although the previous qPCR in vivo studies of C3-tag tumor samples conducted in our lab 
indicated a decrease in IGF1-R and an increase in miR-15b when exposed to caloric restriction 
(Figure 3A),  the difference in such observed data could be due to something as basic as differences 
in the kit used for isolation. For example, there are other references in literature that suggest that 
depending on the protocol or brand name of kit used for isolation of miRNAs, reproducibility may 
vary between methods along with the quality and quantity of collected (36,37). Among various 
column-based kits such as the miRVana total RNA kit, the Norgen total RNA kit, and other 
standard non-kit extraction methods, there were differences in quantity of RNA collected up to 
1000 ng/L. The majority of 260/280 values were consistent for all methods outlined in this study, 
but 260/230 values had great variability and the total % of miRNA from all of these methods 
ranged from approximately 5-25%. In our past studies, total RNA was collected with the use of a 
RecoverAll™ total nucleic acid isolation kit. For this experiment, the Omega Bio-Tek E.Z.N.A. 
Micro RNA Kit was used which uses spin column-based methods to isolate miRNAs and larger 
RNAs into two separate fractions. Based on this outside literature, it is reasonable to conclude that 
differences in total RNA qPCR analysis for miRNAs vs separate qPCR analysis for miRNA and 
mRNA individually could yield alternate results. Furthermore, given the relatively lower 
abundance of miRNAs compared to mRNA and their uniquely small size, they are more difficult 
to amplify and more prone to the introduction of technical bias to results (38). Separating it from 
total RNA may have just been another means by which the sample could have been introduced to 
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more technical or random error. Utilizing a total RNA kit similar to the initial one used in pilot 
studies would have been more beneficial.  
With greater time to work on my in vitro work, my second hypothesis could have been 
further examined with the use of western blotting protein analysis. Activation along the 
PI3K/Akt/mTOR pathway could have been experimentally validated by directly establishing 
levels of phospho-Akt, Akt, and IGF1-R proteins in each treatment group. It is necessary to use 
both methods to fully answer the question of IGF-1 system activation because as shown in other 
literature, transcriptional levels of mRNA and miRNA do not always correlate to the amount of 
protein translated (39,40). There are several post-transcriptional mechanisms taking place with 
other small RNAs other than miRNAs that can alter the amount of protein translation that occurs. 
Additionally, depending on which function they serve, certain subcategories of genes (such as 
those involved in cell signaling) tend to have differing levels of stable mRNA and stable protein. 
Therefore, mRNA and miRNA levels cannot be used as definite indicators of protein status without 
secondary confirmation.  
Another in vitro component that could answer the question of whether or not miR-15b is 
truly driving IGF1-R repression is the use of small double-stranded mimetic RNA molecules. The 
use of mimetics can mimic levels of miRNA in the cell similar to the mature miRNA available 
from endogenous production (41). By elevating levels of miR-15b only, protein and RNA levels 
of IGF1-R could then be quantified in order to determine if its repression is specific to miR-15b 
or an alternate mechanism. If mimetics proved that IGF1-R’s response to caloric restriction was in 
fact miR-15b specific, lentiviral transduction of a plasmid for stable miR-15b expression could be 
employed in the C3-Tag(1) progression cell lines to characterize how miR-15b’s potential anti-
tumorigenic effect is mediated in the cell and how it may differ across cells of increasing 
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tumorigenicity and metastatic capacity. Several methods such as colony-formation assays, flow 
cytometry for cancer stemness, migration assays, and invasion assays could then be performed on 
stable cell lines after lentiviral transduction to ascertain how miR-15b operates within the cell. 
In conclusion, it was determined that miR-15b expression is positively associated with a 
proliferative gene signature and decreased growth factor phosphorylation, and it is negatively 
associated with growth factor signaling as well as classically pro-metastatic pathways. These 
findings were well supported due to their reproducibility across two large patient cohort data sets 
and in the context of both miR-15b expression and miR-15b amplification. Not only this, but data 
was also congruent between RNA-seq data and RPPA data obtained. Hopefully, future in vitro 
studies can help identify the exact mechanism of miR-15b’s potential protective capabilities in 
TNBC. Elucidation of its mechanism could potentially lead to the design of newer and safer 
treatment plans in place of cytotoxic therapy and its detrimental health effects in patients diagnosed 
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